论文部分内容阅读
目的:探讨女性甲基苯丙胺依赖者共病的一般情况,并对相关因素进行调查分析。方法:采用自编调查表,应用美国精神障碍诊断与统计手册第4版(DSM-IV)调查了34例女性甲基苯丙胺依赖者的共病情况,并对相关信息进行归类分析。结果:34例女性甲基苯丙胺依赖者中,共患双向障碍者最多(38.2%);末次吸食后3个月内最易出现精神障碍(44.1%);家族史阳性、童年负性经历、成年后创伤经历是女性甲基苯丙胺依赖者共病的主要相关因素;甲基苯丙胺依赖共病者复吸率较高。结论:女性甲基苯丙胺依赖共病者,更易共患双相障碍;家族史阳性及相关负性社会心理因素是女性甲基苯丙胺依赖者共病和复吸的主要原因;甲基苯丙胺依赖共病者复吸率较高,应加强对此类患者的一体化治疗。
Objective: To investigate the general situation of female methamphetamine dependent co-morbidity and investigate the related factors. Methods: A total of 34 female methamphetamine-dependent comorbid conditions were investigated using a self-designed questionnaire using the Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) in the United States, and the related information was categorized and analyzed. Results: Of the 34 women with methamphetamine dependence, the number of people with comorbid bipolar disorder was the highest (38.2%). Mental disorders were the most likely to occur within 3 months after the last dose (44.1%). Family history was positive, childhood negative experiences, and adulthood Post-traumatic experience is a major factor associated with comorbidity among methamphetamine-dependent women; methamphetamine-dependent comorbidity is associated with a high rate of relapse. CONCLUSIONS: Female methamphetamine-dependent comorbid patients are more likely to share comorbid bipolar disorder; positive family history and related negative psychosocial factors are the major causes of comorbidity and relapse among methamphetamine-dependent women; methamphetamine-dependent comorbidity Patients relapse rate is higher, should be integrated in the treatment of such patients.